PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
48.62
ESG score 90-95% of TGTX's 52.18. Bill Ackman would demand clear ESG improvement catalysts.
63.54
Similar environmental score to TGTX's 64.29. Bruce Berkowitz would investigate if industry environmental norms adequately address climate transition risks.
30.99
Social score below 80% of TGTX's 50.30. Jim Chanos would check for potential social license and litigation risks.
51.34
Governance score exceeding 1.2x TGTX's 41.94. Mohnish Pabrai would examine if this governance advantage creates sustainable competitive advantages through better decision-making.